MIT-led study in Nature Biotechnology uses mRNA-lipid nanoparticles to convert dendritic cells into potent cancer fighters, achieving complete tumor regression in mice. mRNA-loaded nanoparticles repro...
MIT researchers used mRNA to reprogram dendritic cells, achieving complete tumor regression in over 70% of mice with durable immune memory. A new MIT-led study published in Nature Biotechnology demons...
uPAR-targeted CAR T cell therapy shows promising results in solid tumors, with recent clinical trials and FDA designations advancing cancer immunotherapy towards precision medicine. Recent advancement...
Stanford University researchers have engineered NK and T cells with metabolite-sensing receptors like GPR183, enhancing tumor infiltration in mice and offering new hope for CAR-T therapies in solid tu...
A Nature study shows that the balance of polyunsaturated and monounsaturated fatty acids in diet regulates T cell function through ferroptosis, impacting immunity against infections and cancers, with ...
